Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Projected Valuation Of The Asthma Therapeutics Market In The Coming Years?

In recent times, there has been substantial growth in the asthma therapeutics market. It is projected to expand from $30.63 billion in 2024 to $33.11 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.1%. This growth, observed in the historical period, can be credited to an increased awareness regarding asthma management, the upsurge in usage of inhalers and nebulizers, a rise in incidence of allergic asthma due to pollution, augmented governmental efforts towards respiratory health, and the expansion of the healthcare infrastructure in emerging economies.

Expect a surge in the size of the asthma therapeutics market in the following years, as it is predicted to reach $44.53 billion by 2029, developing at a compound annual growth rate of 7.7%. This estimated growth within the forecasted period can be credited to a surge in demand for biologics for asthma therapies, a heightened emphasis on personalized medicine, the growing consumption of digital inhalers and intelligent health gadgets, an increasing incidence of pediatric asthma, and boosted investment into the study and development of groundbreaking therapeutics. Forecasts for the period also spotlight progression in biologic therapies for severe asthma, sophisticated inhaler technologies equipped with digital tracking, the creation of personalized asthma treatment strategies, innovation in drug delivery systems, and the incorporation of artificial intelligence and wearable devices into asthma monitoring.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25702&type=smp

What Drivers Are Accelerating Expansion Of The Asthma Therapeutics Market?

Expectations for the burgeoning asthma therapeutics market are being fueled by the rising incidence of asthma. Asthma is a long-lasting ailment that triggers swelling and inflammation of the airways, constricting the pathways that transport air from the nose and mouth into the lungs. The surge in asthma cases can be attributed to heightened exposure to pollutants, which end up irritating the airways and heightening the chances of initiating this condition. Asthma therapeutics play a crucial role in managing asthma by counteracting airway inflammation, mitigating symptoms, and thwarting asthma episodes. Persistent control treatments like inhaled corticosteroids diminish prolonged inflammation, whereas rapid-release medications such as bronchodilators offer immediate reprieve during bouts of exacerbation. For example, in April 2024, as per Asthma + Lung UK, a charity based in England that offers support to individuals with lung diseases, there was a report of an increase in the number of deaths due to asthma in England, which rose from 1,146 in 2021 to 1,236 in 2022. Consequently, the escalating incidence of asthma is spearheading the expansion of the asthma therapeutics market.

How Is The Global Asthma Therapeutics Market Broken Down By Segment?

The asthma therapeutics market covered in this report is segmented –

1) By Drug Class: Inhaled Corticosteroids (ICS), Long-Acting Beta Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Short-Acting Beta Agonists (SABA), Biologics, Combination Inhalers (ICS + LABA)

2) By Treatment Stage: Acute Treatment, Long-Term Control, Preventive Treatment, Maintenance Regimens, Rescue Medications

3) By Route Of administration: Oral, Inhaled, Intravenous, Subcutaneous

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End-User: Hospitals, Homecare, Specialty Clinics

Subsegments:

1) By Inhaled Corticosteroids (ICS): Fluticasone, Budesonide, Beclomethasone, Mometasone, Ciclesonide

2) By Long-Acting Beta Agonists (LABA): Salmeterol, Formoterol, Indacaterol, Olodaterol

3) By Leukotriene Receptor Antagonists (LTRA): Montelukast, Zafirlukast, Pranlukast

4) By Short-Acting Beta Agonists (SABA): Albuterol (Salbutamol), Levalbuterol, Terbutaline

5) By Biologics: Omalizumab, Mepolizumab, Benralizumab, Dupilumab, Reslizumab

6) By Combination Inhalers (ICS + LABA): Fluticasone + Salmeterol, Budesonide + Formoterol, Mometasone + Indacaterol, Beclomethasone + Formoterol

Which Trends Are Likely To Redefine Growth Paths In The Asthma Therapeutics Market?

Major firms in the asthma therapeutics sector are strategizing to develop novel products, such as fixed-dose combination (FDC) drugs, with the aim to improve treatment outcomes and patient compliance. An FDC drug merges two or more potent pharmaceutical ingredients into a single dosage form, like a tablet or inhaler, tailored to manage a specific medical condition. For example, Glenmark Pharmaceuticals Limited, a pharmaceutical firm based in India, unveiled an innovative fixed-dose combination (FDC) drug, Indacaterol plus Mometasone, for the treatment of asthma in June 2022. Indacaterol operates as a long-acting beta-agonist (LABA), which aids in relaxing airway muscles, and Mometasone functions as an inhaled corticosteroid (ICS), working towards reducing inflammation in the lungs. The design of this FDC aims to provide superior control of symptoms and user-friendly, once-daily dosing, boosting the treatment compliance among moderate to severe asthma patients.

Which Firms Are Making The Biggest Impact In The Asthma Therapeutics Market?

Major companies operating in the asthma therapeutics market are Roche Holding AG, Merck & Co Inc., Pfizer Inc., AstraZeneca plc, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Vertex Pharmaceuticals Incorporated, Sun Pharmaceutical Industries Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited, Mundipharma International Limited, ALK-Abello, Mylan N.V., Whanin Pharmaceutical, Mitsubishi Tanabe Pharma, Allergan plc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/asthma-therapeutics-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Asthma Therapeutics Market?

North America was the largest region in the asthma therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=25702&type=smp

Browse Through More Reports Similar to the Global Asthma Therapeutics Market 2025, By The Business Research Company

Asthma Spacers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/asthma-spacers-global-market-report

Respiratory Disease Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/respiratory-disease-drugs-global-market-report

Allergic Rhinitis Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/allergic-rhinitis-drugs-global-market-report

About The Business Research Company:

With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model